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Results: There was a significant increase in PTHLH expression in OA females relative to NOF females (p ¼ 0.02), however there was no evidence for any significant correlation between PTHLH expression and rs10492367 genotype in OA cartilage. Similarly, there was no correlation between KLHDC5 expression and rs10492367 genotype. In addition, although allelic imbalance was observed, it did not correlate with the OA association SNP genotype. In the U2OS cell line luciferase assays, the OA associated alleles of the intergenic SNPs rs11049206 and rs58649696 resulted in significantly reduced enhancer activities relative to the non-OA alleles (p ¼ 0.0025 and p > 0.0001, respectively). Conclusions: In OA cartilage, our data does not support an association of rs10492367 with OA by mediating its effect on PTHLH or KLHDC5 expression. This may be due to the current analysis being limited to the aforementioned genes in end stage OA cartilage, as the OA associated region may be exerting its effects on other genes, in other tissue types or at different stages of development. However, luciferase reporter assays in an osteosarcoma cell line identified two intergenic SNPs in high LD with the associated SNP rs10492367 that independently resulted in reduced enhancer activity when the OA associated alleles were present. This current research therefore highlights the functional activity of the OA associated region marked by rs10492367.
ADIPOSE TISSUE ASSOCIATED GENES IN HAND OSTEOARTHRITIS IN FINNISH WOMEN
S. H€ am€ al€ ainen, S. Solovieva, T. Vehmas, P. Leino-Arjas, A. Hirvonen. Finnish Inst. of Occupational Hlth., Helsinki, Finland
Purpose: Osteoarthritis (OA) is the most common joint disorder, the joints of the hand being the most frequent site affected. Available evidence suggests that genetic factors may play a major role in the etiology of OA. We chose to analyze in our hand OA material 21 single nucleotide polymorphisms (SNPs) from 10 adipose tissue associated genes (FTO, LEP, LEPR, ADIPOQ, RETN, NAMPT, SERPINA12, ITLN, RARRES2 and APLN) and their association with OA. Methods: Bilateral hand radiographs of 542 occupationally active Finnish female dentists and teachers aged 45-63 years were examined and classified for the presence of OA by using reference images. The genotypes were determined by PCR-based methods. Data regarding finger joint pain and other risk factors were collected by a questionnaire. Associations between the SNPs and hand OA were studied by IBM SPSS statistical package Version 20 using principle component analysis based genetic weighted scores and logistic regression. Results: Association of studied SNPs to hand OA phenotypes were found from LEPR, RARRES2, RETN and APLN genes. FTO Purpose: Recently it has been reported that the rare single nucleotide polymorphism (SNP) rs6094710 is associated with hip osteoarthritis (OA) in European populations. The SNP is a G/A transition, with the Aallele having a frequency of 4%. The A-allele is more common in OA cases versus controls and this association reached genome-wide significance, with a p-value of 7.9 Â 10 À9 and odds ratio of 1.28. rs6094710 is intergenic, maps to chromosome 20q12 and is located upstream of the gene NCOA3, which codes for nuclear receptor co-activator 3. This protein interacts with nuclear hormone receptors and has histone acetyltransferase activity. Prior to the genetic study there were no reports of this protein having a role in OA. rs6094710 is in perfect linkage disequilibrium with rs6094752, a missense polymorphism leading to an amino acid change at position 218 of the NCOA3 protein. However, scrutiny of a variety of public databases reveals that this substitution is benign. This, combined with the absence of other protein-coding changes, make it probable that the 20q12 association mediates its affect by modulating gene expression. The aim of this study therefore was to investigate the effect of genotype at rs6094710 on the expression of NCOA3. Methods: DNA and RNA were extracted from the cartilage of OA patients who had undergone elective joint replacement surgery. DNA was used to genotype patients at rs6094710. cDNA was synthesized from the RNA. Using real-time quantitative PCR (qPCR) we initially assessed whether genotype at rs6094710 correlated with overall expression of NCOA3. We next assessed allelic expression imbalance (AEI) of NCOA3, using the transcript SNP rs6094752 as a perfect proxy for rs6094710. AEI was measured in heterozygotes by pyrosequencing, with DNA providing the 1:1 ratio to which the cDNA ratios were compared. We have previously generated gene expression microarray data for hip cartilage from patients who had undergone joint replacement surgery due to either OA (n ¼ 11) or a neck-of-femur (NOF) fracture (n ¼ 13). This latter cartilage serves as a non-OA control. We used this data to compare the expression of NCOA3 between OA and non-OA hip cartilage. Results: We performed qPCR analysis on the cartilage cDNA of 47 OA patients and observed that overall NCOA3 expression correlated with genotype at rs6094710 (p ¼ 0.021; t-test). Reduced expression of NCOA3 was observed in individuals carrying a copy of the OA associated A-allele. AEI analysis confirmed the reduced expression from this allele, which produced an average of 37% less transcript than the G allele (p < 0.001; t-test). This AEI was also observed in fat pad (also an average 37% reduction) and synovial membrane (51% reduction) from OA patients, and in both males and females. Analysis of our microarray data revealed that NCOA3 is up-regulated 1.27 fold (p ¼ 0.004; Mann-Whitney U test) in OA hip cartilage relative to control NOF cartilage. Conclusions: Our results indicate that the OA association signal marked by rs6094710 is mediating its effect through a reduced expression of the gene NCOA3. Based on our microarray data we hypothesize that NCOA3 expression needs to increase to attenuate the OA disease process but that this increase is hampered in individuals carrying the A-allele of rs6094710, which therefore acts as an OA risk allele. Much more detailed functional studies of the gene and its encoded protein are now merited. Purpose: The aim of the study was to elucidate the genetic background of osteoarthritis (OA) and its correspondence to the genetics of overweight and metabolic syndrome (MetS) in Finnish population. OA and MetS share age and obesity as risk factors, and they both have been considered as an inflammatory disease in which different inflammatory mediators (for example cytokines, lipid derivatives, reactive oxygen species) are released by cartilage, bone and synovium. Obese patients with MetS have higher risk of developing OA than obese patients without MetS. Investigators are now assessing how MetS as a whole is linked to OA, and some have already nominated 'metabolic OA' as the fifth component of MetS. Genomewide association studies (GWAS) have identified several single nucleotide polymorphisms (SNPs) associated with obesity and MetS. One of the most investigated genes has been FTO (fat mass-and obesity-associated) that regulates appetite. Genome-wide association studies have identified that polymorphisms in the FTO gene are associated also with risk of OA. Methods: We chose to analyze 58 SNPs from 45 genes and their association to knee OA in Finnish Health 2000 Survey material. The Health 2000 Survey was conducted in Finland between fall 2000 and spring 2001. It is a representative sample of the Finnish population (n ¼ 8028). The subjects were aged between 30 and 99. Knee osteoarthritis was diagnosed in 6.1 % of men and 8.3 % of women. For the genetic analyses performed in this study we obtained DNA from 402 patients with osteoarthritis and 5348 controls. 186 of the patients were categorized to a group of 'probable osteoarthritis' and 216 to a group of 'definite osteoarthritis' using standard criteria based on medical history, symptom history and physical status. The genotypes were determined by PCR-based methods, iPlex/Sequenom MALTI-TOF mass array analyzer and OpenArray. Background data were collected by a questionnaire. Associations between the SNPs and knee OA were studied by SAS and IBM SPSS statistical package Version 20. Results: The nucleotide substitution A>T in FTO gene (rs9939609) was found to correlate with osteoarthritis. Surprisingly this correlation was statistically significant only in the 'probable osteoarthritis'group (OR ¼ 1,566, 95% CI: 1,040-2,360; p ¼ 0,032) and not in the 'definite osteoarthritis' group (OR ¼ 1,063, 95% CI: 0,713-1,584; p ¼ 0,765). The result remained significant in the 'probable osteoarthritis' group when adjusted with age and gender (OR ¼ 1,608, 95% CI: 1,047-2,470; p ¼ 0,030). When adjusted with BMI, the significance became non-significant (OR ¼ 1,526, 95% CI: 0,990-2,344; p ¼ 0,056). Conclusions: Our results suggest that FTO gene has a role in knee OA. However, it seems that the interaction is at least partly explained by BMI. Purpose: Identification of biomarkers associated with OA disease progression is of critical importance to advance the development of disease modifying therapies. The objective of this study is to investigate if change in semi-quantitative measures of joint morphology over 24 months is associated with clinically relevant progression in knee OA over a 48-month follow-up period. Methods: The FNIH OA Biomarkers Consortium undertook a nested casecontrol study of progressive knee OA within the Osteoarthritis Initiative (OAI). The case group (n ¼ 194) is defined by the combination of knee radiographic outcome (medial tibiofemoral joint space loss (mTF JSL) !0.7 mm) and symptom outcome (persistent worsening in WOMAC pain score, reaching a minimum clinically important threshold of 9 points (change from baseline) on a 0-100 normalised scale), each achieved for the first time at the 24, 36 or 48 month follow-up compared to baseline. Main inclusion criteria were a Kellgren Lawrence grade (KLG) 1, 2 or 3 at baseline from central reading and availability of knee radiograph and magnetic resonance images (MRIs) at baseline and 24 months. Controls (n ¼ 406) were knees eligible for the study that did not meet both endpoint criteria, and consisted of: 200 super controls with no worsening of either factor (pain or mTF JSL), 103 subjects with JSL but no pain increase and 103 with a persistent increase in pain but not JSL. Knee MRIs (not contrast enhanced) at baseline, 12 and 24 months were scored using the MRI Osteoarthritis Knee Score grading systems for bone marrow lesions (BMLs), intercondylar synovitis and effusion. BML, synovitis and effusion score changes were categorized as improved, no change, worsened within grade, worsened by one grade, or worsened by more than one grade. Analyses were performed for change in the whole knee and, for BMLs only, also for change in the medial tibio-femoral compartment. Logistic regression was used to assess the risk of case status adjusting for baseline age, sex, BMI, KLG and baseline pain. Results: 194 cases of mean age 62 years, mean BMI 30.7 and 57% female were compared to 406 controls of mean age 61 years, mean BMI 30.7 and 60% female. BML change from BL to 24 months was associated with case status -particularly the maximum change in BML score in the medial tibiofemoral compartment OR 1.5 (95% CI 1.3,1.8) and change in number of subregions affected in the medial tibiofemoral compartment OR 1.5 (95% CI 1.1,1.8) (Table) . Change in effusion, OR 2.2 (95% CI 1.6,2.8), and synovitis, OR 2.2 (95% CI 1.4,3.6), were both strong predictors of case status. There were differential effects of BML change on the 3 types of case status (pain case vs. JSL case vs. JSL and pain case, each compared to super controls) with strong association with JSL cases as opposed to pain cases. Conclusion: Change in semi-quantitative MRI features (BMLs, synovitis and effusion) are potent predictors of clinical outcome. Intriguingly, the prediction of clinical outcome from BMLs, synovitis and effusion appears to be associated with stronger effects on structure. Purpose: Quantitative MRI (qMRI) measures in knee osteoarthritis (OA) capable of predicting key clinical endpoints such as total knee replacement (TKR) have promise as prognostic biomarkers. Recently, it was reported that very large BML volume (measured semi-quantitatively) in the medial tibiofemoral joint predicted a TKR 1 year later. We now use a recently validated rapid qMRI software tool to examine whether BML volume and change in volume predicts TKR 1 and 2 years later. The purpose of this study was to examine the longitudinal relationship between BML volume and those who received a TKR, compared with control knees with the same radiographic grade that did not receive a TKR. Materials and methods: A nested case-control study was conducted in the Osteoarthritis Initiative (OAI), a multicenter cohort of 4796 participants with or at risk for knee OA. Subjects who received TKR by the 48month visit who also had MRI scans (3T sagittal intermediate-weighted turbo spin-echo fat-suppressed, 0.357 Â 0.357 Â 3.0 mm, TR 3200 ms, TE 30 ms, intermediate-weighted) available for the 12 and 24 month visit prior to the TKR were designated cases. Cases were matched 1:1 with subjects who did not receive TKR but were the same radiographic disease grade (K-L grade score), same gender and age of the case. Quantitative BML volumes in the tibia, femur and patella were
426

428
